Search for: "Chilcott v. Chilcott"
Results 21 - 40
of 63
Sorted by Relevance
|
Sort by Date
28 Oct 2013, 7:23 am
Warner Chilcott Company LLC v. [read post]
26 Sep 2013, 7:11 am
Warner Chilcott Company, LLC v. [read post]
22 Oct 2017, 9:59 pm
Co. v. [read post]
12 Dec 2011, 1:28 pm
Warner Chilcott and Mayne Pharma International v. [read post]
4 Jan 2009, 12:08 pm
View the complaint here.Warner Chilcott Laboratories Ireland Ltd. et al. v. [read post]
5 Apr 2011, 2:35 pm
District Court for the District of New Jersey in Medeva Pharma Suisse A.G. v. [read post]
24 Dec 2008, 3:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Classen v Biogen (not precedential): Federal Circuit applies Bilski to the life sciences (Holman's Biotech IP Blog) (Inventive Step) (Hal Wegner) (EFF) (Patently-O) (Patent Prospector) (The Fire of Genius) (Patent Baristas) (Managing Intellectual Property) (Patent Docs) (Spicy IP) General India: Investing farmers… [read post]
29 Oct 2013, 2:32 pm
Warner Chilcott Co., LLC v. [read post]
18 Nov 2014, 1:36 pm
The "reasonable to try" aspect of obviousness arose in the case:In re O’Farrell, 853 F.2d 894, 903–04 (Fed. [read post]
15 Sep 2010, 6:09 am
The manufacturers and marketers involved include Sanofi Aventis, Warner Chilcott, Roche, GlaxoSmithKline and Merck. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment calculation… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
16 Jan 2009, 5:00 am
: BMS v Hetero (GenericsWeb) India: Adding innovation to Ayurveda! [read post]
14 Nov 2007, 8:59 pm
Ranbaxy Femcon Fe: Warner Chilcott v. [read post]
2 Feb 2011, 3:52 am
General Technical symposium to address access to medicines, patent information and freedom to operate (WIPO) Brazil: Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) India: Protection of Plant Varieties and Farmers’ Rights Authority appoints new Chairperson (Spicy IP) Italy: Tribunale di Milano: Mere filing of application for marketing authorization of a generic drug does not constitute infringing activity: Eli Lilly… [read post]
27 Oct 2010, 3:38 am
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
9 Jul 2020, 10:56 am
Vijay Tharwani v. [read post]
19 Nov 2020, 8:08 pm
Vijay Tharwani v. [read post]
9 Jul 2020, 10:56 am
Vijay Tharwani v. [read post]
26 Oct 2011, 2:30 am
Par files suit to stop government from expanding its reach (FDA Law Blog) US: Preparing for Mayo v. [read post]
